Journal September 19, 2026 4 min read

Common Misconceptions About the Cortisol Rhythm

Cortisol is a glucocorticoid hormone with a circadian and ultradian rhythm. This page examines common misconceptions about that rhythm and what the research literature actually reports.

peptides-pro Editorial

Cortisol is a glucocorticoid hormone of the hypothalamic-pituitary-adrenal (HPA) axis, also referred to as hydrocortisone (11β,17α,21-trihydroxypregn-4-ene-3,20-dione). Its molecular formula is C21H30O5 and its molecular weight is 362.46 g/mol. In the research literature, cortisol is studied as the principal endpoint of HPA-axis output, and its rhythm is described as both circadian and ultradian [2].

The work centres on the HPA axis and its glucocorticoid receptor signalling, with cortisol release governed by tightly controlled circadian and ultradian rhythms [2].

Research Studies

Cortisol and the circadian rhythm in human sleep-restriction models

A common misconception is that cortisol follows a single daily peak with no finer structure. The evidence describes cortisol as being released in both circadian and ultradian rhythms, meaning that pulsatile secretion occurs across the 24-hour cycle rather than as one isolated event [2]. In human sleep-restriction protocols, sleep loss has been reported to increase evening cortisol and to decrease daytime testosterone [1]. The same source notes that chronic sleep loss affects approximately 1 in 3 adults in the US and is associated with stress-induced insulin resistance [1].

Cortisol and insulin resistance in controlled laboratory settings

Another misconception is that cortisol's metabolic effects are independent of the timing of its release. A registered study is examining the impact of timed cortisol release, or differently timed cortisol rhythms, on insulin resistance in both men and women undergoing sleep restriction [1]. The stated purpose is to examine these hormones in a controlled laboratory environment [1]. This is a study protocol; it does not report an outcome, and no effect on insulin resistance should be inferred from it.

Cortisol and ultradian pulsatility in the human HPA axis

It is sometimes assumed that ultradian cortisol pulses are a rodent-specific finding. The evidence states that rodent studies and mathematical models have clarified the mechanisms of ultradian pulsatility, while the human picture is described as less quantitatively resolved [2]. This is a reference-only source; it supports the page rather than forming its content.

Cortisol and Cushing syndrome in pregnancy

A misconception holds that cortisol excess always presents in a predictable pattern. Cushing syndrome is described as a major cause of secondary osteoporosis, and postpartum fractures associated with Cushing syndrome have occasionally been reported [3]. Fractures occurring during pregnancy in patients with Cushing syndrome are described as exceptionally rare, and several cases of adrenal Cushing syndrome that became apparent or worsened during pregnancy have been reported [3]. This is a reference-only source.

Cortisol and Epitalon in preclinical models

Epitalon is a synthetic tetrapeptide derived from the amino acid composition of Epithalamin, a polypeptide extract derived from the bovine pineal gland [4]. Current preclinical evidence suggests that Epitalon may activate telomerase by upregulating human telomerase reverse transcriptase (hTERT), and in aged primates Epitalon has been studied in relation to pineal-related endpoints [4]. This is a reference-only source, and the findings are preclinical; they do not establish a human cortisol-rhythm effect.

Cortisol rhythm and sleep loss: comparing reported directions

The table below compares the directions reported in the evidence for two hormones under sleep restriction. It is a summary of what the cited sources state, not a set of measured values.

Hormone	Reported direction under sleep loss	Source
Cortisol	Increased in the evening	[1]
Testosterone	Decreased during the day	[1]

Cortisol and the limits of animal and in vitro evidence

Where the evidence is animal-only or in vitro, this page says so plainly. The ultradian pulsatility mechanisms are described as clarified largely through rodent studies and mathematical models [2]. The Epitalon findings are described as preclinical, including work in aged primates [4]. Neither category should be read as a human cortisol-rhythm finding.

Cortisol and what the evidence does not establish

The evidence block does not provide a human dose, a treatment protocol, or an outcome for any cortisol-rhythm intervention. The registered study is a protocol examining timed cortisol release and insulin resistance under sleep restriction [1]; it is not a results report. No claim about personal health, dosing, or clinical benefit can be supported from these sources.

If you are reading this for personal health reasons

The materials described here are sold for laboratory research only, and we do not provide dosing or medical guidance. Anyone considering a compound for themselves should speak to a licensed clinician. Nothing on this page is a substitute for individual medical advice.